Last updated on December 2019

Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)

Brief description of study

An Open Label Long-Term Study to Evaluate the Safety and Tolerability of Seladelpar in Subjects with Primary Biliary Cholangitis (PBC)

Detailed Study Description


To evaluate the long-term safety and tolerability of seladelpar


To evaluate the long-term efficacy of seladelpar

Clinical Study Identifier: NCT03301506

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.